Market Place
Sourcing Support
Recordati acquires EUSA Pharma & its 4 rare disease drugs, but analysts question
06 Dec 2021 //
ENDPTS
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT®
02 Dec 2021 //
PRESS RELEASE
BeiGene, EUSA Announce NMPA Approval of SYLVANT for iMCD
02 Dec 2021 //
BUSINESSWIRE
BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.
17 Aug 2021 //
BUSINESSWIRE
EUSA Pharma & BeiGene Announce Acceptance of a BLA for SYLVANT®
25 Jan 2021 //
BUSINESSWIRE
EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA
09 Nov 2020 //
BUSINESSWIRE
AVEOOncology and EUSA Pharma Announce Annals of Oncology Publication
05 Nov 2020 //
MARKETWATCH
EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab
01 Jul 2020 //
BUSINESSWIRE
EUSA Pharma nabs new executives, including the recently ousted Abeona CEO
15 May 2019 //
FIERCE BIOTECH
SMC endorses EUSA Pharma’s Qarziba
13 Nov 2018 //
PHARMA TIMES
EUSA Announces Global Rights to SYLVANT from Janssen for $115 Million
18 Jul 2018 //
BUSINESSWIRE
J&J Unit to Sell Sylvant Rights to U.K. Drugmaker Eusa Pharma
18 Jul 2018 //
BLOOMBERG
EUSA Pharma: NICE approves QARZIBA (dinutuximab beta) for neuroblastoma
14 Jul 2018 //
BUSINESSWIRE
NICE backs Qarziba for children with high-risk neuroblastoma
12 Jul 2018 //
PHARMA TIMES
EUSA Pharma Announces Sale of Critical Care Business to SERB Pharmaceuticals
11 Jul 2018 //
PR NEWSWIRE
EUSA Pharma (UK) Limited Fotivda Receives Approval In Europe
23 Nov 2017 //
EMA
EUSA bags EU approval for kidney cancer drug
30 Aug 2017 //
PHARMA TIMES
NICE knocks back advanced kidney cancer drug duo
14 Aug 2017 //
PHARMAFILE
EU approves first immunotherapy for neuroblastoma
10 May 2017 //
PHARMA TIMES
EUSA Pharma Announces Acquisition of Global Rights to Arcoral® Tab from Arcoral
11 Apr 2016 //
PR NEWSWIRE
Threshold dumps two-thirds of its staff after a crushing failure
21 Dec 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.